Combination therapy with bone marrow stromal cells and FK506 enhanced amelioration of ischemic brain damage in rats

Combination therapy using FK506 enhanced the anti-apoptotic and anti-inflammatory effects of MSCs and increased the survival of transplanted cells, leading to expansion of the therapeutic time window for MSCs.